Similar to aFib-RS, POSTN mRNA levels were increased in the CMS4 patient subset (Supplementary Fig. 7a) and independently predicted poor outcome in the overall CRC population (Supplementary Fig. 7b–d). The gene discussed is POSTN; the disease is colorectal carcinoma.